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MASTER CHART
INTRODUCTION
Dr. Archie Brain, between 1981 and 1987, developed a new way of linking artificial and 
anatomical airways. This new concept known as laryngeal mask airway was different from 
other forms of airway management.1
Combining the advantages of a non-invasive facemask and the more invasive tracheal 
tube, the laryngeal mask airway was created to fill an important functional gap that existed 
between standard methods of airway control that were in use then.
Originally the device was recommended as a better alternative to the face mask. But ever 
since its development, the LMA has challenged the assumption that tracheal intubation is the 
only acceptable way to maintain a clear airway and provide positive pressure ventilation.
Though the LMA has provided the convenience of “Hands-free” anesthesia, for some 
anaesthesiologists, the combination of LMA and positive pressure ventilation evokes fear of 
inadequate ventilation, gastric distension and pulmonary aspiration of gastric content.
To  overcome  the  above  complications  Dr.Archie  Brain,  designed  the  proseal  LMA 
(PLMA) and it was introduced in 2000. Modifications were designed to enable separation of 
gastrointestinal and respiratory tracts, improve airway seal, enable positive pressure ventilation 
and diagnose mask displacement.2  A drain tube (DT) enables diagnosis of mask misplacement 
and  also  aims  to  reduce  risks  of  gastric  inflation,  regurgitation  and  aspiration  of  gastric 
contents.
There are 59 randomized control trials and 79 case reports about PLMA. There are 27 
Proseal LMA Randomized control trial studies and summed data to compare insertion time, 
insertion success and airway seal pressure with the LMA.
There are four reports  comparing Proseal  LMA and tracheal  intubation,   one during 
laparoscopic  cholecystectomy,3 two during gynecological  laparoscopy4,5 and one comparing 
haemodynamic changes during airway insertion / removal6.
The Proseal LMA has been more thoroughly evaluated by peer reviewed publications 
than other new supraglottic airway devices introduced in the last 5 years. These include the 
laryngeal tube7  laryngeal tube sonda, airway management devices, pharyngeal airway express, 
Cobra  perilaryngeal  airway.  Unlike  these  devices,  many  of  which  have  been  modified  on 
several occasions since introduction, the Proseal LMA has not. Comparative evaluations are 
only available with the laryngeal tube7 and laryngeal tube sonda.
Hence a prospective randomized study was designed to compare the  Proseal LMA and 
Endotracheal tube regarding haemodynamic changes, positive pressure ventilation and gastric 
distension during laparoscopic procedures.

AIM OF THE STUDY
  
The aim of the study was to evaluate the effectiveness of Proseal LMA compared to 
endotracheal  tube  during  laparoscopic  procedures  based  on  the  Haemodynamic  Changes, 
Ventilatory Parameters and Gastric Distension. 
PROSEAL LMA
The proseal laryngeal mask airway (PLMA) was designed and developed by Archie 
Brain in 2000, with a primary goal to construct a laryngeal mask with improved ventilatory 
characteristics and that also offered protection against regurgitation and gastric insufflation.
DEVICE DESCRIPTION8,2
The proseal LMA is made from medical grade silicone and is reusable. It has four main 
components1
1) Mask
2) Inflation line with pilot balloon
3) Airway tube
4) Drain tube
The cuff of the mask has identical proportions but different dimensions amongst sizes. All 
the components are latex free. It is recommended that proseal LMA be used a maximum of 40 
times before being discarded.
MODIFIED FEATURE INTENDED PURPOSE
A  second  cuff  attached  to  the  dorsal 
surface.
• To improve seal by pushing the ventral 
cuff  more  firmly  into  the  periglottic 
tissue.
A ventral cuff that is larger proximally • To form a better seal by plugging gaps 
in the proximal pharynx.
A large conical – shaped distal cuff to 
deeper bowl.
• To  form  a  better  seal  with  the 
hypopharynx.  To  form  a  better  fit  in 
laryngopharynx.
A parallel,  narrow bore, double – tube 
configuration
• To increase the stability and to improve 
seal  by allowing the tongue to form a 
more effective plug.
A flexible, wire-reinforced airway tube  • To  prevent  the  double-tube 
configuration from being too stiff.
A drainage tube • To facilitate gastric tube insertion 
• To divert regurgitated fluid away from 
the respiratory tract 
• To prevent gastric insufflations 
• To  provide  information  about  device 
position.
A drainage tube distal  aperture  that  is 
sloped anteriorly.
• To allow the deflated tip to form a fine 
leading edge for insertion.
A  plastic  supporting  ring  around  the 
distal drainage tube.
• To prevent the drainage tube collapsing 
when the cuff is inflated
A drainage tube that passes within the 
bowl 
• To avoid altering the external shape of 
the cuff.
• To function as a mask aperture bar for 
the accessory vent
A  rectangular  depression  in  the 
proximal bowl tube
• To function as an accessory ventilation 
channel
• To prevent pooling of secretions at the 
distal aperture of the airway
A built in bite block • To prevent airway obstruction 
• To prevent damage to the device during 
biting.
• To provide information about depth of 
insertion.
Locating strap • To help  fuse  the  airway  and  drainage 
tube together. 
• To prevent finger slipping of the tube
No back plate • To keep the proximal cuff in midline
• To reduce rigidity and allow room for 
the dorsal cuff
No Mask aperture bars. • To reduce resistance to gas flow 
ACCESSORIES
Introducer Tool
The introducer tool is a reusable clip-on / clip – off device that comprise a thin, curved, 
malleable, metal blade with a guiding handle similar to the intubating LMA. The inner surface 
and curved tip are coated with a thin layer of transparent silicone to reduce the risk of trauma. 
The distal end fits into the locating strap and the proximal end clips into the airway tube above 
the bite block with the proximal drainage tube resting to one side.
Cuff Deflator
This is a dedicated deflation device to aid complete deflation for successful sterilization, 
optimum insertion and positioning in the patient.
SIZES AVAILABLE
Proseal 
LMA 
Mask 
Size
Patient 
Selection 
Guidelines
Proseal 
LMA 
Airway 
Tube ID 
(mm)
Maximum 
Cuff 
Inflation 
Volume 
(Air)
Maximum Size
Gastric
Tube
ETT
(mm)
  
FOB
 (mm)
1 ½ 5-10 kg 6.4 7 ml 10 French 4.5 3.5
2 10-20 kg 6.4 10 ml 10 French 4.5 3.5
2 ½ 20-30 kg 8.0 14 ml 14 French 4.5 3.5
3 30-50 kg 8.0 20 ml 16 French 5.0 4.0
4 50-70 kg 8.0 30 ml 16 French 5.0 4.0
5 70-100 kg 10.0 40 ml 18 French 6.0 5.0
These are maximum volumes that should never be exceeded. It is recommended that the 
cuff be insufflated to 60cm H2O intracuff pressure.9
USE
PREPARATION  FOR USE
CLEANING
Thoroughly wash the cuff and airway tube, drain in warm water using dilute (8-10% w/
w) Sodium bicarbonate solution until all visible foreign matters are removed. Ensure the areas 
behind the proseal LMA introducer strap and under the internal drain tube are clean. Clean the 
tubes using a small soft bristle brush (approximately ¼ inch (or) 6mm in diameter for adult size 
devices). Gently insert the brush through proximal end of the drain tube. Thoroughly  rinse the 
cuff, airway tube and drain tube, with  warm flowing tap water to remove residues. Carefully 
inspect the proseal LMA to ensure that all visible foreign matters have been removed. Care 
should be taken to ensure that water does not enter the device through the valve. 
STERILISATION
Steam autoclaving  is  the  only  recommended  method  for  sterilisation  of  the  proseal 
LMA. Immediately prior to steam autoclaving, deflate the cuff, pulling the syringe backwards 
to obtain a high vacuum. For complete deflation it is recommended that proseal LMA cuff 
deflator is used.  Ensure that both the syringe  used to deflate the cuff and the valve is dry. The 
maximum temperature should not exceed 1350C or 2750F. The proseal LMA introducer and 
cuff deflator should be cleared and sterilised in the same manner as proseal LMA. The same 
cautions apply.
PERFORMANCE TESTS
Non – Clinical tests that must be conducted before each use of the device.
1) VISUAL INSPECTION
Ensure that the thin walled section of the drain tube lying within the mask bowl is not 
torn or perforated, and that there is no contamination between the tube and the mask.
Examine the transparency of the tubes. Do not use the proseal LMA if the tubes are 
discolored as this impairs the ability to see and effectively remove foreign particles during 
cleaning, or to see regurgitated  fluids during use.
Examine the surface of the device for damage including cuts, tears or scratches.
Examine the 15mm connector. It should fit tightly into the outer end of the airway tube.
2) INFLATION AND DEFLATION
Using a syringe,  fully deflate the device,  so that the cuff walls are tightly flattened 
against  each  other.  Remove  the  syringe  from  the  valve  port.  Examine  the  cuff  walls  to 
determine whether they remain tightly flattened against each other. Do not use if the cuff walls 
reinflate immediately and spontaneously, even if only slightly.
Inflate  the  cuff  from  complete  vacuum  with  50% more  air  than  the  recommended 
maximum inflation volume. Any tendency of the cuff to deflate indicates a presence of a leak 
and should be evident within 2 minutes. Examine the symmetry of the inflated cuff.  There 
should be no asymmetrical bulging at either end or sites. Inspect the interior of the drain tube 
from both ends of the mask. Ensure that the thin walled section of the tube is not collapsed, 
where it passes through the distal end of the mask.
While the device remains 50% over inflated, examine the inflation pilot balloon. The 
balloon shape should be a thin slightly flattened elliptical shape not spherical.
PRE-INSERTION PREPARTION
Prior to insertion and sterilisation of the device, the cuff should be fully deflated to a 
flattened wedge shape. The cuff walls should not have any wrinkles and the cuff should be 
straight at the distal end.
This shape facilitates atraumatic insertion and correct position in the patient. It reduces 
the risk of entry of the distal end into the valleculae  or glottis and avoids it becoming caught 
against epiglottis or arytenoids. The correct cuff shape can be accomplished through use of 
proseal LMA cuff deflator as follows:
Insert the proseal LMA, partially inflated, with its distal end exactly level with the tip of 
the indicating arrow as shown. The mask bowl should face curved surface of cuff deflator. 
Release the hands to compress the mask
Use a syringe to deflate the  cuff
Whilst deflating, pull back gently on the inflation line to ensure all air is removed from 
the mask.
Deflate to a vacuum, disconnect the syringe and release the proseal LMA.
Ensure that the back of the mask is straight, without any curvature of the distal end; the 
distal end should be maximally flattened.
ALTERNATIVE METHODS OF CUFF DEFLATION
• Using original silicone LMA proseal cuff deflator
• Manually by compressing the distal end between finger and thumb
• Lubrication of the posterior surface of the cuff should be performed just before insertion 
to prevent drying of the lubricant.  Lubricate only the posterior surface of the cuff to 
avoid blockage of the airway aperture or aspiration of the lubricant. It is recommended 
that a bolus of lubricant can be applied to the posterior tip of the deflated cuff. It is not 
necessary to spread of the lubricant over the mask surface. A water soluble lubricant 
such as K-Y jelly, should be used.
INSERTION8
Insertion Success Rates
Fisher’s method shows that the first time success rate for the LMA is higher than 
the PLMA, but overall success is similar. One study reported a higher first-time success rate 
with  the  introducer  tool,  but  this  finding  awaits  confirmation.  The  introducer  tool  makes 
insertion  easier  because  it  occupies  less   space  than  finger,  and  facilitates  full  depth  of 
insertion. Overall insertion success is higher for the PLMA than the Laryngeal tube airway 
(100% versus 92%).  The highest  insertion success  rates  are  with the  gum-elastic  bougie  – 
guided technique; both Brimacombe et al and Howath et al reported 100% success at the first 
attempt.
PROCEDURE
Check the size of PLMA, shape of the cuff and its lubrication
POSITIONING
Ideal recommended position is extension of the head with flexion of neck (the sniffing 
position)
INSERTION METHODS
Having acquired an adequate anaesthetic depth, the device may be inserted using one of 
the following methods:-
• using PLMA introducer
• Using index finger or the thumb
• Using gum elastic bougie
1) PLMA introducer Insertion Technique:-16
• Place the tip of the proseal LMA introducer into the retaining strap at the rest of the cuff.
• Fold the tubes around the convex surface of the blade 
• Fix the proximal end of the airway tube into the matching slot in the tool
• Press the tip of the cuff upward against the hard palate and flatten the cuff against it. 
Slide the cuff further inwards against the palate.
• Jaw may be pushed downwards22 momentarily to assist entry between the teeth.
• Keeping the PLMA introducer blade close to the chin, rotate the device inwards, in one 
smooth circular movement. During insertion follow the curve of the rigid insertion tool. 
The jaws should not be held widely open during this movement as this may allow the 
tongue and epiglottis to drop downwards, blocking further passage of the mask. Advance 
into the hypopharynx  until a definite resistance is felt.
• Before  removing  the  introducer,  a  non-dominant  hand  is  brought  from  behind  the 
patient’s head to stabilize tubes. This prevents the device from being pulled out of place, 
when introducer is removed. . It also permits the device to be pushed further inwards in 
the event that full insertion has not been achieved by the Introducer alone. At this point, 
the PLMA should be correctly located with its tip firmly pressed up against the upper 
esophageal sphincter
• Remove the introducer in same circular motion.
2) Index Finger Insertion Technique:-
• Finger insertion technique is not recommended for PLMA sizes 1 ½ - 2 1/2 . These sizes 
have dedicated introducer.
• Hold the PLMA like a pen, with the index finger pushed into the introducer strap.
• Under direct vision, press the tip of the cuff upward against hard palate and flatten the 
cuff against it.
• As the index finger passes further into the mouth, the finger joint begins to extend. The 
jaws should not be held widely open during this movement as this may allow the tongue 
and epiglottis to drop downwards, blocking passage of the mask.
• Push the jaw downwards,22with middle finger or instruct an assistant to pull the lower 
jaw downwards momentarily.
• Using the  index finger  to  guide the  device,  press  backwards  toward the  other  hand, 
extending counter pressure. Do not use excessive force.
• Advance the device into the hypopharynx until a definite resistance is felt. Full insertion 
is not possible unless the index finger is fully extended and the wrist is fully flexed.
• Before removing the finger, the non-dominant hand is brought from behind the patient’s 
head to press down on the airway tube. This prevents the device from being pulled out of 
place when the finger is removed. It also permits completion of insertion in the event 
that this has not been achieved by the index finger alone. At this point, the PLMA should 
be  correctly  located  with  its  tip  firmly  pressed  up  against   the  upper  esophageal 
sphincter.
• Remove the finger
3) Thumb Insertion Technique:-
Thumb insertion technique is not recommended for PLMA sizes 1 ½ - 2 1/2 . These 
sizes have a dedicated introducer.
This is useful if it is impossible to get access to the patient from behind, or to rapidly 
gain an airway while initiating CPR
• Operator stands facing the patient
• The thumb is inserted into strap
• Insertion is similar to that using index finger
• The thumb should be used to extend the head just prior to completing insertion. This 
prevents  the  unopposed  backward  movement  of  the  thumb  causing  undesired  head 
flexion.
4) Gum Elastic Bougie Guided Insertion12,13
The  PLMA drainage  tube  is  primed  with  a  lubricated,  gum elastic  bougie  with  its 
straight end first and with sufficient length protruding from the proximal drainage tube to 
grab it. 
• the gum elastic bougie is placed in the esophagus with its straight end first under gentle 
laryngoscope guidance. 
• The scope is removed
• The PLMA is railroaded along the bougie, following the palatopharyngeal  curve, and 
using the digital – insertion technique.
• The cuff then is inflated, and ventilation is commenced.
• The  PLMA should  be  held  to  prevent  dislodgement  during  removal  of  gum elastic 
bougie.
• Alternatively, the gum-elastic bougie can be placed in the esophagus first and the PLMA 
attached second.
• Alternatively,  the laryngoscope can be used in  situ and PLMA inserted under  direct 
vision.
DEVICE INFLATION
After insertion, the tubes should emerge from the mouth directed caudally.  Without 
holding  the  tubes,  inflate  the  cuff  with  just  enough  air  to  obtain  an  intra  cuff  pressure 
equivalent to approximately 60cm H2O.9
During cuff inflation do not hold the tube as this prevents the mask from settling into its 
correct location. A small outward movement of the tube is often noted as the device seats itself 
in the hypopharynx.
Never over inflate the cuff after insertion. Cuff should be inflated with at least  25% of 
the maximum recommended volume to ensure effective seal with gastrointestinal tract. Signs of 
correct placement may be one of the following:-                    
• slight outward movement of the tube upon inflation.
• The presence of smooth oval swelling in the neck around the thyroid and cricoid area.
DEVICE FIXATION13
Once  inflated  the  device  should  be  fixed  in  place  using  fish  mouth  taping  (Maxilla  to 
Maxilla). Gentle pressure is applied to outer end of  the airway tube as it is fixed.  This 
ensures that the tip of the mask is pressed securely against the upper oesophageal sphincter. 
Correct fixation is more critical for PLMA because any migration proximally of tip from 
hypopharynx will result in air leakage up the DT during positive pressure ventilation(PPV).
INSERTION PROBLEMS
• An inadequate depth of anaesthesia may result in coughing and breath holding during 
insertion. Should this occur, anaesthesia should be deepened immediately.
• If the patient’s mouth cannot be opened sufficiently to insert the mask, first ensure that 
the  patient  is  adequately  anaesthetized.  An  assistant  can  be  asked  to  pull  the  jaw 
downwards.
• The cuff must press against the palate throughout the maneuver, otherwise the tip may 
fold back on itself or impact on an irregularity or swelling in the posterior pharynx. If the 
cuff fails to flatten or begins to curve over as it is advanced, it is necessary to withdraw 
the mask and reinsert it . If difficulty persists with the chosen technique, one of other 
techniques described should be used.
Diagnosis of correct and incorrect mask position and maneuvers  to correct them:
Malposition occurs in approximately 5% to 15% of patients at the first attempt, but most 
occurrences are recognized easily and corrected. 
Fine malpositions have been described, including the following:-16,17,20
1) Distal cuff in laryngopharynx (7%)
2) Distal cuff in glottic inlet (3%)
3) Distal cuff folded over (3.4%)
4) Severe epiglottic downfolding (0.5%)
5) Glottic compression (0.4%)
Maneuvers to correct, incorrect mask position2
a) Cuff in laryngopharynx or glottis:- 
When  the  proseal  is  not  inserted  deeply  enough,  the  distal  cuff  will  sit  in  the 
laryngopharynx. When it takes an anterior path during insertion, the distal cuff will sit in the 
glottic inlet. Pushing the PLMA  further usually corrects the laryngopharyngeal malposition, 
but glottic malposition requires reinsertion.
b) Cuff folded over:-
 Folding over occurs when the distal cuff impacts against the posterior oropharyngeal 
wall. Several techniques have been used to correct this malposition, including the following:-
1) Reinsertion using a lateral approach with the cuff entering the oropharynx from the 
side of the hard palate.
2) Reinsertion with the drainage tube stiffened by priming it to the distal end with a 
gum elastic bougie or stylet.
3) Gum-elastic bougie guided re-insertion
4) Digital correction by sweeping a finger behind the cuff.
c) Severe epiglottic downfolding:-
This occurs  when the  epiglottis  is  dragged inferiorly  by the  cuff  and completely 
covers the glottic inlet. To correct this occurrence, the proseal should be reinserted with the 
head and neck in a more extreme sniffing   position, or with jaw thrust applied, or with he 
epiglottis elevated through the use of a laryngoscope.
TESTS FOR PLACEMENT
1) Depth of Insertion10
It  has  been observed that  when most  of  the  bite  block was outside  the  patient’s 
mouth, PLMA was frequently malpositioned. The total length of a bite block is 5-6cm in 
both size 4 & 5 and the middle of the bite block is  located 18.0 and 19.0cm from the 
beveled tip of the DT in size 4 & 5 respectively. For women, mean depth of insertion has 
been found to be 18.6cm2 and for men 20.9cm. Usually most of the bite block is inside 
patient’s mouth and anaesthetists  must suspect malposition in < ½ of the bite block is 
within the mouth. When this happens, other tests should be done to confirm positioning.
2) Test for obstructed airway
Manually  ventilate  the  patient  and  observe  rise  and  fall  of  the  chest  wall,  the 
capnograph  for a square wave tracing and the feel and filling of an anaesthesia bag.
3) Soap bubble Test18,19
This is done to evaluate the seal with GIT. A small amount of non-toxic bubble solution 
is dispensed in a bottle cap.  New examining  gloves are put on,  fingertip made wet with 
the solution and the DT touched to create a membrane. Any leak during PPV will cause 
the bubble solution to bulge. This is a useful aid when learning to use the PLMA. This is 
also a valuable technique to routinely monitor safe PLMA usage.
USES
1) Confirms PLMA location behind the cricoid cartilage.
2)Detects negative DT pressure and aerophagia with spontaneous ventilations
3)Diagnose dangerous oseophageal insufflation during PPV.
4) Lubricant Jelly Test
This test also evaluates the seal with GIT. A bolus of 0.5ml to 1ml of lubricant jelly is 
placed in proximal end of the DT to seal it. If there is a leak from the DT, this bolus of jelly is 
blown off.
5) Suprasternal  Notch Test15,21
This is to determine whether the leading edge of PLMA lies behind cricoid cartilage. A 
non-toxic soap-solution is placed across the proximal end of DT creating a membrane. The 
suprasternal notch is then gently tapped. A pulsating soap membrane with tapping confirms the 
tip location behind the cricoid cartilage.
Mechanism Tapping the suprasternal notch leads to compression of distal tip of PLMA 
causing distortion of DT. This makes the extremely sensitive soap membrane to bulge with 
tapping and if this happens, Suprasternal notch test is positive.
6) Gastric Tube Placement Test
When there is no leak up the drain tube, then insertion of a gastric tube is attempted via 
DT  without  using  much  force.  This  gives  information  about  the  DT  patency  which  is 
mandatory for safe use of PLMA.
OROGASTRIC TUBE INSERTION
The primary function of the drain tube is to provide a separate conduit from and to the 
alimentary tract. Ensure the tube is at or above room temperature and well lubricated with a 
water based jelly  before insertion. This is then passed down DT of proseal LMA without any 
haste or force. A slight resistance is encountered as the tip of catheter passes gently against 
upper oesophageal sphincter. There is an inherent resistance to gastric tube insertion after 23cm 
of passage, due to an angulation of degrees in the passage of DT to its tip. There may be a 
difficulty in passing a gastric tube due to following reasons:-
1) Selection of too large gastric tube
2) Inadequate lubrication
3) Use of cooled gastric tube
4) Cuff over inflation
5) Malposition of PLMA16
The advantages of inserting a gastric tube are that:-
• It allows removal of gas or fluid from the stomach
• The process of insertion provided information about the position  or patency of drainage 
tube 
• It can  function as a guide to PLMA re-insertion if accidental displacement occurs.14
The disadvantages are that
• There is a risk of tracheal placement
• There is a risk of trauma, the worst – case scenario being oesophageal perforation
• The presence of gastric tube may trigger regurgitation by intervening with  oesophageal 
sphincter function and gastric tube blocks the drainage tube so that gas and fluid  cannot 
escape from esophagus.
Tests for drainage tube air leak and patency:-
Air Leak
Air  leak  up  the  drainage  tube  during  PPV  demonstrates  that  gastro-intestinal  and 
respiratory tracts are not isolated from one another. Large volume air leaks can be detected 
readily by listening over the drainage tube or feeling the air with a hand. But small-volume is 
detected best by placing water – based lubricant or a soap bubble over the end of the draining 
tube.
Drains tube patency and testing:-
If the drainage tube is not patent it cannot fulfill of its functions. Testing of drain tube 
patency is mandatory for safe use of PLMA. There are 3 tests of drainage tube patency.
• Passage of gastric tube
• Passage of FOB
• The suprasternal notch test15,21 
Other potential indications of PLMA:-
1) Emergency medicine
2) Difficult airway
3) Paediatric use23,24
LAPAROSCOPIC SURGERY – ANAESTHETIC IMPLICATIONS
Physiological changes during laparoscopy25
Three major forces that uniquely alter the patient’s physiology during laparoscopy
• Increase in intra-abdominal pressure
• Effects of patient positioning
• Carbon dioxide
EFFECTS OF PNEUMOPERITONEUM26
Cardiovascular Changes
• Increase in heart rate
• Increase in mean arterial pressure
• Increase in systemic vascular resistance
• Increase in myocardial filling pressure
• Increase in Central Venous Pressure
• Increase in Pulmonary Capillary Wedge Pressure
• Decrease in Cardiac Output
Regional Circulatory Changes
Cerebral:  Increased intra cranial pressure ‘
(Due to decreased venous drainage of lumbar plexus due to inferior vena cava 
compression)
Hepatoportal :  Decreased portal & hepatic blood flow
Gastrointestinal Tract: Intramural Acidosis 
        Splanchnic Ischemia
Renal: Decreased renal blood flow
Decreased Glomerular filtration rate
Lower Limb: Decreased femoral vein blood flow
Respiratory Changes
• Decreased functional residual capacity
• Decreased vital capacity
• Restricted diaphragmatic excursion
• Decreased compliance
• Ventilation perfusion abnormality
• Raised airway pressure
• Endobronchial intubation
• Cephalad displacement of mediastinum
EFFECTS OF HYPERCARBIA 27
Cardiovascular system
Local Effects
• Direct depression of myocardial contractility  and rate of contraction.
• Direct stimulation of myocardial irritability and arrythmogenicity
Systemic Effects
• Stimulation of CNS and sympatho adrenal system
• Increase in cardiac output
• Increase in heart rate
• Increase in blood pressure
• Increase in Central Venous Pressure
Respiratory System
• Increase in minute ventilation
• Bronchodilatation
• Pulmonary Vasoconstriction
Central Nervous System
•  PCO2 – Direct cortical depression
•       PCO2 – Stimulates sub-cortical hypothalamic areas 
   Increase in cortical excitability & Seizures
•       PCO2 – Cortical and sub cortical suppression
• Increase in cerebral blood flow
• Increase in intracranial pressure
Neuro- Endocrine System
• Increased epinephrine and nor-epinephrine
• Increased cortisol
• Increased renin / aldosterone
• Increased anti-diuretic hormone
• Increased atrial natriuretic peptide 
Renal System
Sympathetic Stimulation
Catecholamine release
Decrease renal cortical blood flow
Afferent arterial constriction Increase abdominal pressure > 15mm Hg
Decreased GFR
Decreased Urine Output
Gastro Intestinal System
Diffusion of Co2 into bowel
Post Operative Nausea and Vomiting
EFFECTS OF POSITIONING26 
Reverse Trendelenberg
 Decreased right atrial pressure
 Decreased venous return
 Decreased pulmonary capillary wedge pressure
 Decreased mean arterial pressure 
 Decreased cardiac output
Trendelenberg position
• Decreased Vital capacity
• Decreased functional residual capacity
• Decreased lung compliance
• Increase in cerebral blood flow
• Increase in cardiac output
COMPLICATIONS26
Injuries from instruments
 Bleeding
 Organ perforation
 Injury to blood vessels
 Subcutaneous emphysema
 Peritonitis
 Wound infection
Due to pneumo peritoneum
 Bowel ischemia
 Gastric Regurgitation
 Compression of inferior venacava
 Decreased venous return
 Decreased cardiac output
 Increase in intra-thoracic pressure
 Pneumothorax
 Barotrauma
 Atelectasis
 Nausea and Vomiting
Due to Hypercarbia
 Acidosis
 Arrythmias
 Hypertension
 Increase in heart rate
 Increase in intracranial pressure
 Co2 Embolism
Trendelenberg Position
• Venous congestion of head and neck
• Increase in venous pressure
• Increase in intracranial pressure
• Retinal haemorrhages & Detachment
• Increased intraocular pressure 
• Endobronchial Intubation
• Ventilation perfusion mismatch
• Hypoxia
• Neuropathy & Nerve injuries
• Corneal & Conjunctival edema
Advantages of Laparoscopy26
• Minimally invasive
• Decreased blood loss
• Decreased postop pain
• Decreased postop ileus
• Early ambulation
• Decreased wound related complications
• Decreased hospital stay
• Cost effective
• Quick return of respiratory functions.
REVIEW OF LITERATURE
The proseal  laryngeal  mask Airway  designed by  Dr.  Archie  Brain,  is  based  on  the 
classic Laryngeal Mask Airway and it was introduced in 2000.
Modifications  were  designed to  enable  separation  of  gastrointestinal  and  respiratory 
tracts, improve the airway seal, enable controlled ventilation and diagnose mask misplacement. 
A drain tube enables diagnosis of mask misplacement and also aims to reduce risks of gastric 
inflation, regurgitation and aspiration of gastric contents.
So, PLMA gained widespread popularity for Laparoscopic surgeries.  Over the years, 
case reports, surveys, and small series have described the uses, comparison with other SADS, 
and its rare complications.
1)Lu pp,Bricombe J,Yang C,Shym;Br JA;200241
They did study to test the hypothesis that PLMA is a more effective ventilatory device 
than LMA for Laparoscopic  cholecystectomy. They concluded that PLMA is more effective 
ventilatory device for Laparoscopic cholecystectomy than LMA. Further they recommended 
against the use of the LMA for Laparoscopic  Cholecystectomy. 
2) Maltby JR, Beriault MT, Watson NC, Liepert DJ, Can J. Anaesth 20023
The study was done to compare PLMA with endotracheal tube with respect to pulmonary 
ventilation and gastric distension during laparoscopic cholecystectomy. They concluded 
that a correctly seated PLMA or endotracheal tube equally effective pulmonary ventilation 
without clinically significant gastric distension in all non-obese patients.
3) Natalini G, Canza G, Rosano A, Dell Agnolo P, J Clin, Anaesthesia ; 200342
They compared the airway seal and frequency of sorethroat with the LMA-Proseal 
and LMA during Laparoscopic  surgery.  They concluded that  the  LMA – proseal  and 
LMA show similar airtight  efficiency during Laparoscopy .
4) Malt by JR, Beriault MT, Watson NC, Fick GH 2003 4
They conducted a study to compare the laryngeal mask airways, LMA and PLMA 
with the endotracheal tube with respect to pulmonary ventilation and gastric distension 
during gynaecologic laparoscopy. They came to a conclusion that correctly placed LMA 
and PLMA is as effective as an endotracheal tube for positive pressure ventilation without 
clinically important gastric distension in non-obese and obese patients.
5) Piper SN, Triem JG, Rohm KD, Maleck WH; Schollhorn TA; 20045
The aim of  study  was  to  assess  the  practicality  of  PLMA during  laparoscopic 
surgery with pneumoperitoneum  compared to Endotracheal intubation. They concluded 
that  PLMA  is  a  convenient  and  practicable  approach  for  anaesthesia  in  patients 
undergoing laparoscopic surgery.
6) Joseph Brimacombe  MB,  Christian  Keller  MD,  Lawrence  Brimecombe  MG;  Anas.  
Analg 2002;43
The aim of study was to compare PLMA & LT Airway in paralyzed Anaesthetised 
adult patients undergoing pressure controlled ventilation, with respect to insertion success 
rates  and  time,  efficacy  of  seal,  ventilatory  parameters,  airway  interventional 
requirements.  They  concluded  that  PLMA  offers  advantages  over  the  laryngeal  tube 
airway in most technical aspects of airway management in paralyzed patients.
7) Cornelivs J. O’ Connor Jr, Carl J. Borromeo; Michael S. Stin; Anaesth Analg 200215
They evaluated the Suprasternal Notch Test in 50 consecutive patients. In all 50 
patients the SSN Test has been positive. They believed that positive SSN Test reliably 
indicates the presence of the PLMA tip behind cricoid cartilage.
8) M.S. Stin and C.J. O’Connor Jr; BJ Anaes. 200310
They measured depth of insertion in satisfactorily positioned PLMAS.
They concluded most of the integral bite block lies within the oropharynx. It was never 
normal for the entire bite block to stick out of mouth. The position of the integral bite 
block relative  to the upper  incisors  gives  valuable information during assessment of 
PLMA position.
9) Christian  Kellar  ,  MD;  Joseph  Brimacombe,  MB;  Axel  Kleinsasser  MD;  Alen 
Loeckinser, MD; Anaes Analg 200044
In  this  randomized,  cross  –  over  cadaver  study,  they  determined  whether  PLMA 
prevents aspiration of regurgitated fluid.
They concluded that correctly placed PLMA allows fluid in esophagus to bypass the 
oropharynx  in the cadaver model.
10) Brimecombe J; Keller C. European J Anasth 200345
They evaluated the stability of the LMA – Proseal and LMA in different head and neck 
positions. 
They  concluded  that  the  anatomical  positions  of  the  PLMA and  LMA is  stable  in 
different head and neck positions,  but head-neck-flexion and rotations are associated 
with  an  increase,  and  head-neck-extension  with  a  decrease  in  oropharyngeal  leak 
pressure and intra-cuff pressure.
11) Michael S. Stin, MD, Cornelins J.O’ Conner Jr; Anaes Analg 46  2002:95:1782-87
They used a hyperventilation Tests, maximum minute ventilation Test (MMV Test) to 
aid in diagnosis of upper airway obstruction alters PLMA insertion.
The patients in this study was briefly hyperventilated for 15S yielding a MMV value 
equal to 4x(breaths/15s) x (exhaled tidal volume).
12) N.R. Evans, S.V. Gardner and M.f.M. James,47 Br J Anaesth; 2002; 88; 4584-587
They did  a study in 103 patients, by filling the hypopharynx with methylene – blue dyed 
saline introduced down the drainage tube once the mask was in place. At the beginning 
and end of the procedure, a FOB was passed down the airway tube to observe any dyed 
saline in the bowl of mask.
They concluded  a correctly positioned PLMA can isolate the airway from the fluid in 
hypopharynx.
13) Shinichi Kihara, MD; Joseph Brimacombe; Anasth analg; 2005;97;280-284 39
They did a study based on PLMA size selection in Anaesthetised male and female adult 
patients.  
They concluded, when sex is used to select the appropriate size of proseal LMA, Size 4 
preferable for women ; Size 5 for men.
14) Christian Keller MD; Joseph Brimacombe MB; Anal Kleingasser MD; and Lawrence 
Brimacombe; Anasth Analg 2002; 94; 737-74044
They evaluated PLMA as a temporary ventilatory device in grossly and morbidly obese 
patients before laryngoscope – guided Tracheal intubation
15) Rachael M. Craren, Stephen R. Larer ; Tim M.Cook, Jerry P.Nolan CJ Anasth: 2003; 
50;718-20
They  evaluate  the  use  of  PLMA  to  facilitate  percutaneous  dilatational  tracheostomy 
(PDT)
They concluded that PLMA provides a reliable airway and allows effective ventilation 
during PDT. The passage of FOB through the PLMA and glottis is easy and provides a 
clear view of upper trachea.
16) Nyarwaya JB, Mazoit JX, Samiik; anaesthesia; 1994 33
Cardio-respiratory changes Induced by pneumo-peritoneum and head-up tilt may generate 
alveolar ventilation to perfusion ratio changes and increased systemic vascular resistances. 
The reliability of end-tidal carbon dioxide tension and pulse oximetry in predicting arterial 
carbon dioxide partial pressure and arterial oxygen saturation may therefore be affected. 
So a study was designed to find if pulse oximetry and end-tidal carbon dioxide tension 
monitoring  were  reliable  during  laparoscopic  surgery.  They  concluded  that  end-tidal 
carbon-dioxide partial pressure and pulse ox metric saturation allow reliable monitoring of 
arterial carbon dioxide partial pressure and arterial oxygen saturation in the absence of 
pre-existing cardio-pulmonary disease and / or acute perioperative disturbance.
17) Wurst H. Schurte – Steinberg H, Finsterer U; Anaesthetist; 1995 48
Two groups of 22 patients each were studied in a prospective randomized fashion during 
laparoscopic cholecystectomy and carbon dioxide pneumoperitonium with regard to end-
tidal and arterial PCO2  and pulmonary elimination of carbon dioxide. They found that it 
during  laparoscopic  cholecystectomy  with  carbon  dioxide  pneumoperitonium  patients 
were ventilated with constant minute ventilation, a moderate increase in PaCo2  of about 
10mm  Hg  occurred.  They  concluded  that  it  PaCO2  is  to  be   held  constant  during 
pneumoperitonium, minute ventilation has to be increased by about 40%
18) Bures E, Fusciardi J, Languetot H; Alta Anaesthesiol Scand 49; 1996
During laparoscopic cholecystectomy the arterial – end-tidal Co2 gradient (Pa-ETCO2) has 
been variously shown to be unchanged, increased, decreased or even negative. The goal of 
this  study  was  to  evaluate  Pa-ETCO2,  and   to  determine  the  proper  contribution  of 
ventilatory  adequacy in  regard  to  the  increase  of  PETCO2.  They  concluded that  only 
erroneous Co2 loading,  and not  ventilatory  adequacy,  could explain such  increase  in 
PETCo2 and PACo2 in cases of limited Co2 insufflating pressure in ASA l-ll patients.
19) Hirvonen EA, Poikolainen EO, Paakkonen ME; 56 Surg Endosc; 2000
The  increased  intra-abdominal  pressure  during  pneumo-peritoneum,  together  with  the 
head-up tilt used in upper abdominal laparoscopies would be expected to decrease venous 
return to the heart. The goal of this study was to determine whether laparoscopy impairs 
cardiac performance when preventive measures to improve venous return are taken, and to 
analyze the effects of positioning, anaesthesia,  and increased intra-abdominal pressure. 
With the passive head-up tilt  in awake and Anaesthetised patients,   the cardiac index, 
central venous pressure, and pulmonary capillary wedge pressure decreased, and systemic 
vascular resistance increased. They concluded that the head-up positioning accounts for 
many of the adverse effects in haemodynamics during laparoscopic cholecystectomy.
20) EC – Ganzovria, Avramor MN, Budacs, Moric M Tuman KJ Anaesth ; 2003 6
They evaluated haemodynamic changes,  between PLMA versus ETT. They concluded 
that  PLMA  had  more  haemodynamic  stability  than  ETT  in  response  to  insertion  / 
intubation, intra-OP and after removal / Ex-tubation 
MATERIALS AND METHODS
STUDY DESIGN
This study was a randomized prospective comparative study.
STUDY SETTING AND POPULATION
After  obtaining patients  written informed consent  and institutional  ethical  committee 
clearance, the study was carried out in the General Surgery Operation Theatre, Government 
General Hospital, Chennai from July 2006 to August 2006.
The study was conducted in 40 adult patients of either sex between the age group of 18 – 
60  years  belonging  to  ASA  –  I  &  II  posted  for  elective  laparoscopic  surgeries 
(Cholecystectomy & Appendicectomy) at the Government General Hospital, Chennai.
Inclusion Criteria
• Adults of either sex
• 18 – 60 years
• ASA physical status I & II
• Mallampati Class I – II
Exclusion Criteria 36
• Known difficult airway
• Cervical spine disease
• Mouth opening < 2.5cm
• Patients with risk of aspiration like 
i) H/o hiatus hernia
ii) Reflux oesophagitis
Study Method
Patients were randomized into 2 groups
1) Group I (Group E) – ETT for airway management
2) Group II (Group P) – PLMA for airway management
All Patients were  fasted overnight. They were given aspiration prophylaxis with Inj-Ranitidine 
50mg I.V. and Inj-Metaclopramide 10mg I.V. 1 hr before surgery 37, 38.  Patients premedicated 
with Inj-Glycopyrrolate 0.2mg 1hr before surgery. After the placement of monitoring devices 
and  preoxygenation,  all  the  patients  were  induced  with  Inj-Propofol  2.5mg/kg  I.V.,  Inj.-
Fentanyl 2µg/kg I.V., and Inj-Vecuronium 0.1mg/kg I.V. Patients were intubated with cuffed 
ETT of appropriate sizes in the group ETT and appropriate sizes of the PLMA in the PLMA 
Group. 
 
Group ETT
For women ETT size 7.0/7.5mm and for males size 8.0/8.5mm was used. Cuff inflated 
to maximum Of 25-30cm H2O. Position was confirmed clinically and with capnography. After 
placement of ETT, Ryle’s tube was introduced for  continuous drainage.
Group PLMA
In the PLMA Group PLMA was introduced as per the body weight chart. The mask was 
inserted using the index finger as recommended by the anufacturer 40. 
The cuff was inflated to a pressure of 60cm H2O, which was maintained at this pressure 
throughout the procedure with cuff pressure monitor. Closed circle breathing system with 
sodalime  was used. Correct placement of the device was confirmed  clinically and by 
capnography. In addition the following tests were carried out to check whether the PLMA was 
correctly placed:-
• Square wave capnography
• The gel displacement Test 18
•  The Suprasternal Notch Test 15
No. of attempts was noted . An easy of insertion was defined as the one in which there 
was no resistance to insertion in the pharynx in a single maneuver. In a difficult insertion there 
was resistance to insertion or more than one maneuver was required for the correct placement 
of the device.
A maximum of three insertion attempts were allowed before placement of the device 
was considered failure.
PLMA was fixed in a manner fish mouth tapping (maxilla to maxilla) A gastric tube 
(Size 14-16) was then passed  through drain tube. Ease of placement of the gastric tube was 
recorded and its correct placement confirmed by injection of air and epigastric auscultation. 
Anaesthesia  was  maintained  with  N2O:  O2 (2:1),  isoflurane  1% and  Neuromuscular 
blockade maintained with inj. Vecuronium 0.02mg/kg 
  Positive pressure ventilation with mechanical ventilator was instituted with a set tidal 
volume of 8ml/kg FiO2 0.33%, respiratory rate 12 b/p/m I/E of 1:2  in both the groups. The 
following parameters were noted intra-operatively
I. Heart rate, systolic, diastolic and mean blood pressure  before induction, and 1min, 5min 
after  insertion  of  PLMA  /  intubation  with  ETT  and  5  min  after  achieving 
pneumoperitoneum and then at every 5min intervals.
II. Saturation (SPO2) and end tidal Co2(ETCo2),  was observed in same manner 
III. SPO2  was maintained > 95% and ETCo2 < 45, by adjusting the FiO2, respiratory rate, 
and tidal volume. If the SPO2 decreased  the FiO2 was increased and if the SPO2 did not 
improve, the tidal volume was increased to 10ml / kg. If ETCo2 increased above 45, 
respiratory rate was increased to 14 b.p.m, then 16 b.p.m. followed by tidal volume 
increase up to 12ml/kg.
 A period of three minutes was allowed between adjustments of FiO2, tidal volume, and 
respiratory rate. When SPO2 was  90-94% the oxygenation was graded as suboptimal and failed 
if it was <90% with ETCo2 readings, sub-optimal ventilation was between 45-50 or failed if the 
reading was > 50.
A peak airway pressure was recorded in the same time points and the intra-abdominal 
pressure were kept between 12 to 14mm Hg.
* Episodes of gastric distension  during the procedure was noted by the surgeon and they 
were recorded.
* All the patients in the PLMA group were tested for any occurrence of regurgitation 
using litmus paper postoperatively.
Residual blockade was reversed with 1.2mg atropine and 2.5mg neostigmine.
Post operatively the following problems were noted
                Cough
• Sore throat
• Nausea
• Vomiting
OBSERVATION AND RESULTS
The proseal LMA (PLMA) and Endotracheal Tube (ETT) were compared based on the 
following parameters:-
* Haemodynamic Changes : Heart rate
Systolic blood pressure
Diastolic blood pressure
Mean arterial pressure
 before induction, 1min, 5min after Intubation/insertion,  5min after pneumoperitoneum 
and then every 5min till  extubation. Then 5min after extubation.
* Ventilatory Parameters:
End tidal Co2 (ETCo2)
Oxygen saturation (SPO2)
Tidal volume and respiratory rate 
FiO2
Airway Pressure
Noted as the same manner as above.
• Gastric distension
• No. of attempts of insertion / intubation
• No of attempts to pass a Ryle’s tube
Study material
A total of 20 cases each was randomly allocated to one of the following two groups of 
study viz. Group I – Endo tracheal Tube (ETT); Group II – proseal LMA.
Statistical method
The  descriptive  statistics  of  the  variables  studied  are  represented  as  two-way  tables.  The 
categorical factors are represented by the number and frequency (%) of cases. The continuous 
variables are represented by measures of central frequency (like mean, median & mode) and 
deviation (say, standard deviation and range). The differences in the proportions are tested for 
statistical significance using non-parametric Chi-square test for variables measured on nominal 
scale. When testing for two factors, the Mann-Whitney “U” test or Wilcoxon two sample test 
(by Kruskal-Wallis “H” test which is equivalent to chi-square) is used. For variables measured 
on a continuous scale, when testing for two groups, Student “t” test is used to test for statistical 
significance in the differences of the two means.
Table 1: Distribution of age of cases by groups$
Age Gr. I Gr. II p-value
No. of cases
Mean
S.D.
Median
Mode
Range
20
29.0
12.97
25
20
17-62
20
28.7
13.10
24
20
17-62
0.94
$ Not statistically significant
The mean age was observed to be almost the same in Group I than Group II and not statistically 
significant.
Table 2: Distribution of cases by groups and sex$
Sex Gr. I (n=20) Gr. II (n=20)
No. % No. % p-value
Male
Female
10
10
50.0
50.0
12
8
60.0
40.0
0.53
$ Not statistically significant
A male preponderance is forthcoming in Group II but the difference in the distribution between 
the two groups is not statistically significant. 
Table 3: Distribution of weight of cases by groups$
Weight Gr. I Gr. II p-value
No. of cases
Mean
S.D.
Median
Mode
Range
20
54.9
5.80
52.5
50
50-66
20
53.9
5.41
50.5
50
50-66
0.60
$ Not statistically significant
The distribution of cases by weight and the difference in the mean values are observed to be not 
statistically significant between Group I and Group II. 
Table 4: Mean Distribution of cases by groups and HR
HR Gr. I
(n=20)
Gr. II
(n=20) p-value
Before induction
Mean
SD
93.1
13.5
85.0
19.7
0.14
1 min after intubation 
/insertion 
Mean
SD
94.6
18.27
87.0
27.4
0.31
5 min after intubation 
/insertion
Mean
SD
92.5
8.41
82.2
14.38
0.008*
5 min after 
pneumoperitoneum
Mean
SD
99.1
9.83
86.8
14.71
0.003*
5- min
Mean
SD
96.8
9.99
84.1
13.37
0.002*
10-min
Mean
SD
94.8
9.25
82.2
12.58
<0.001*
15-min
Mean
SD
93.4
8.36
79.6
12.57
<0.001*
20-min
Mean
SD
91.0
8.3
77.5
11.82
<0.001*
25-min
Mean
SD
89.1
7.87
77.4
11.00
<0.001*
30-min (n=30)
Mean
SD
n=16
86.5
8.86
n=14
79.2
11.28
0.06
35-min (n=24)
Mean
SD
N=13
86.6
10.63
N=11
78.0
12.11
0.08
40-min (n=16)
Mean
SD
N=7
82.4
10.75
N=9
72.8
7.31
0.05*
45-min (n=11)
Mean
SD
N=6
79.8
14.1
N=5
73.6
5.03
0.38
5 min after extubation
Mean
SD
97.1
12.17
78.6
10.2
<0.001*
* statistically significant
The distribution of cases by grade of Heart Rate (HR) and the mean values were observed to be generally 
statistically significant between Group I and Group II at the majority of different time points viz. between 5 minute 
after intubation and 25 min, at 40 min and 5 min after extubation.
Table 5: Distribution of cases by groups and systolic blood pressure
Systolic blood pressure Gr. I
(n=20)
Gr. II
(n=20) p-value
Before induction
Mean
SD
122.7
9.10
124.7
9.26
0.51
1 min after intubation 
/insertion
Mean
SD
130.4
16.42
110.1
14.31
<0.001*
5 min after intubation 
/insertion 
Mean
SD
119.4
14.21
112.4
10.24
0.08
5 min after 
pneumoperitoneum
Mean
SD
137.4
16.72
120.8
13.48
0.001*
5-min
Mean
SD
130.1
10.78
117.6
14.58
0.004*
10-min
Mean
SD
129.0
9.93
117.8
12.26
0.003*
15-min
Mean
SD
125.0
7.65
116.7
9.21
0.004*
20-min
Mean
SD
124.9
7.97
115.2
9.80
0.001*
25-min
Mean
SD
124.4
6.63
115.1
9.08
<0.001*
30-min (n=30)
Mean
SD
N=16
123.9
6.99
N=14
116.7
13.01
0.07
35-min (n=24)
Mean
SD
N=13
121.8
7.72
N=11
115.8
13.31
0.19
40-min (n=16)
Mean
SD
N=7
122.4
10.64
N=9
119.8
12.71
0.66
45-min (n=11)
Mean
SD
N=6
121.7
13.46
N=5
122.4
14.57
0.93
5 min after extubation
Mean
SD
134.1
5.9
117.1
7.6
<0.001*
* statistically significant
The  distribution  of  cases  and  the  mean  values  of  systolic  blood  pressure  were  observed  to  be  generally 
statistically significant between Group I and Group II at the majority of different time points viz. at 1 minute after 
intubation, between 5 minutes after pneumoperitoneum and 25 min and at 5 minutes after extubation. 
Table 6: Distribution of cases by groups and diastolic blood pressure
Diastolic blood pressure Gr. I
(n=20)
Gr. II
(n=20) p-value
Before induction
Mean
SD
82.7
8.24
84.3
6.94
0.51
1 min after intubation 
/insertion
Mean
SD
87.2
13.35
73.0
15.55
0.004*
5 min after intubation 
/insertion
Mean
SD
77.7
21.52
74.9
11.05
0.61
5 min after 
pneumoperitoneum
Mean
SD
96.2
14.24
84.2
12.51
0.008*
5-min
Mean
SD
88.6
11.74
80.2
13.39
0.04*
10-min
Mean
SD
87.3
11.43
83.0
11.05
0.23
15-min
Mean
SD
84.4
8.64
79.8
10.73
0.15
20-min
Mean
SD
83.6
8.99
78.3
12.46
0.13
25-min
Mean
SD
83.7
8.85
80.0
11.21
0.26
30-min (n=30)
Mean
SD
N=16
83.8
9.67
N=14
80.9
13.45
0.49
35-min (n=24)
Mean
SD
N=13
83.2
8.41
N=11
79.5
12.75
0.40
40-min (n=16)
Mean
SD
N=7
81.3
10.56
N=9
82.8
13.02
0.81
45-min (n=11)
Mean
SD
N=6
78.0
9.06
N=5
85.2
10.47
0.25
5 min after extubation
Mean
SD
87.3
9.86
80.9
9.08
0.04*
* statistically significant
The distribution of cases and the mean values of  diastolic blood pressure were observed to be statistically 
significant between Group I and Group II at the following different time points viz. 1 minute after intubation, 5 
minutes after pneumoperitonium,  and 5 minute after estuation. 
Table 7: Distribution of cases by groups and MAP
MAP Gr. I
(n=20)
Gr. II
(n=20) p-value
Before induction
Mean
SD
95.9
7.95
97.7
7.03
0.44
1 min after intubation 
/insertion
Mean
SD
101.3
13.88
84.5
12.34
<0.001*
5 min after intubation 
/insertion
Mean
SD
95.2
14.63
88.6
10.1
0.10
5 min after 
pneumoperitoneum
Mean
SD
110.1
11.22
95.6
11.95
0.001*
5-min
Mean
SD
101.6
11.22
92.2
14.11
0.03*
10-min
Mean
SD
101.4
10.46
93.7
11.21
0.03*
15-min
Mean
SD
97.5
7.30
92.0
9.57
0.05*
20-min
Mean
SD
97.1
7.62
90.0
11.39
0.03*
25-min
Mean
SD
97.4
7.86
92.1
10.08
0.07
30-min (n=30)
Mean
SD
N=16
96.7
8.15
N=14
93.6
14.17
0.48
35-min (n=24)
Mean
SD
N=13
95.5
7.16
N=11
91.9
12.83
0.40
40-min (n=16)
Mean
SD
N=7
95.0
9.92
N=9
94.8
12.49
0.97
45-min (n=11)
Mean
SD
N=6
93.3
9.54
N=5
93.4
7.64
0.99
5 min after extubation
Mean
SD
101.6
7.4
92.6
8.07
<0.001*
* statistically significant
The distribution of cases and the mean values of MAP were observed to be statistically significant between 
Group I and Group II at the following different time points viz. 1 minute after intubation, between 5 minutes after 
pneumoperitonium and 20th hour and 5 minute after estuation.
Table 8: Distribution of cases by groups and ET CO2$
ETCO2 Gr. I
(n=20)
Gr. II
(n=20) p-value
Before induction
Mean
SD
31.3
2.5
31.5
2.97
0.82
1 min after intubation 
/insertion
Mean
SD
33.2
2.88
33.1
2.88
0.91
5 min after intubation 
/insertion
Mean
SD
33.3
3.15
33.5
3.3
0.88
5 min after 
pneumoperitoneum
Mean
SD
37.9
4.61
37.8
4.59
0.92
5-min
Mean
SD
37.2
2.43
37.2
2.43
-
10-min
Mean
SD
38.1
3.49
38.2
3.51
0.96
15-min
Mean
SD
36.5
1.79
36.4
1.76
0.86
20-min
Mean
SD
36.1
1.83
36.0
1.79
0.79
25-min
Mean
SD
35.3
2.83
35.2
2.80
0.91
30-min (n=30)
Mean
SD
N=15
35.5
3.6
N=15
35.4
3.58
0.96
40-min (n=20)
Mean
SD
N=10
35.8
1.81
N=10
36.0
1.70
0.80
45-min (n=14)
Mean
SD
N=7
35.9
1.86
N=7
35.9
1.86
-
$ Not statistically significant
The  distribution  of  cases  and  the  mean  values  of  ETCO2 were  observed  to  be  generally  not  statistically 
significant between Group I and Group II at all the different time points. 
Table 9: Distribution of cases by groups and TV$
TV Gr. I
(n=20)
Gr. II
(n=20) p-value
Before induction
Mean
SD
518.5
59.41
511.0
50.7
0.67
1 min after intubation 
/insertion
Mean
SD
434.5
42.86
433.5
40.95
0.94
5 min after intubation 
/insertion
Mean
SD
436.5
44.28
430.5
40.32
0.66
5 min after 
pneumoperitoneum
Mean
SD
443.5
44.75
437.5
41.91
0.66
5-min
Mean
SD
454.0
39.79
434.5
41.1
0.14
10-min
Mean
SD
440.5
44.42
434.5
41.1
0.66
15-min
Mean
SD
435.5
42.98
434.5
41.1
0.94
20-min
Mean
SD
440.5
44.42
439.5
42.73
0.94
25-min
Mean
SD
490.5
149.82
489.5
149.68
0.98
30-min (n=30)
Mean
SD
N=14
451.4
47.05
N=14
450.0
45.06
0.94
40-min (n=20)
Mean
SD
N=10
448.0
52.66
N=10
446.0
49.93
0.93
45-min (n=14)
Mean
SD
N=7
428.6
50.14
N=7
428.6
50.14
-
$ Not statistically significant
The distribution of cases and the mean values of TV were observed to be generally not statistically significant 
between Group I and Group II at all the different time points.
Table 10: Distribution of cases by groups and RR$
RR Gr. I
(n=20)
Gr. II
(n=20) p-value
Before induction
Mean
SD
14.9
1.31
14.9
1.33
0.91
1 min after intubation /insertion
Mean
SD
12.1
0.45
12.1
0.45
1.00
5 min after intubation /insertion
Mean
SD
12.0
0.0
12.0
0.0
-
5 min after pneumoperitoneum
Mean
SD
12.3
0.98
12.3
0.98
1.00
5-min
Mean
SD
13.8
0.89
13.7
0.98
0.74
10-min
Mean
SD
13.7
0.98
0.37
0.98
1.00
15-min
Mean
SD
13.7
0.98
0.37
0.98
1.00
20-min
Mean
SD
13.8
1.1
13.8
1.1
1.00
25-min
Mean
SD
13.8
1.12
13.8
1.12
1.00
30-min (n=30)
Mean
SD
N=15
13.8
1.19
N=15
13.0
3.53
0.37
40-min (n=20)
Mean
SD
N=10
13.8
1.14
N=10
13.8
1.14
1.00
45-min (n=14)
Mean
SD
N=7
13.7
1.38
N=7
13.7
1.38
1.00
$ Not statistically significant
The distribution of cases and the mean values of RR were observed to be almost similar in Group I and Group II  
at all the different time points and hence not statistically significant.
Table 11: Distribution of cases by groups and FI O2$
FIO2 Gr. I
(n=20)
Gr. II
(n=20) p-value
Before induction
Mean
SD
49.2
3.8
49.2
3.8
1.00
1 min after intubation 
/insertion
Mean
SD
33.0
0.0
33.0
0.0
-
5 min after intubation 
/insertion
Mean
SD
33.9
3.8
33.9
3.8
1.00
5 min after 
pneumoperitoneum
Mean
SD
33.0
0.0
33.0
0.0
-
5-min
Mean
SD
33.0
0.0
33.0
0.0
-
10-min
Mean
SD
33.0
0.0
33.0
0.0
-
15-min
Mean
SD
33.0
0.0
33.0
0.0
-
20-min
Mean
SD
33.0
0.0
33.0
0.0
-
25-min
Mean
SD
33.0
0.0
33.0
0.0
-
30-min (n=30)
Mean
SD
N=15
33.0
0.0
N=15
33.0
0.0
-
40-min (n=20)
Mean
SD
N=10
33.0
0.0
N=10
33.0
0.0
-
45-min (n=14)
Mean
SD
N=7
33.0
0.0
N=7
33.0
0.0
-
$ Not statistically significant
The distribution of cases and the mean values of FIO2 were observed to be almost similar in Group I and Group 
II at all the different time points and hence not statistically significant.
Table 12: Distribution of cases by groups and AWP$
AWP Gr. I
(n=20)
Gr. II
(n=20) p-value
Before induction
Mean
SD
17.5
3.09
17.4
3.63
0.92
1 min after intubation 
/insertion
Mean
SD
18.7
2.70
18.6
2.60
0.91
5 min after intubation 
/insertion
Mean
SD
19.7
3.25
19.6
3.20
0.92
5 min after 
pneumoperitoneum
Mean
SD
22.2
2.62
21.8
2.45
0.62
5-min
Mean
SD
23.2
2.78
22.9
2.41
0.72
10-min
Mean
SD
23.1
2.78
22.9
2.57
0.86
15-min
Mean
SD
23.1
3.01
23.2
3.1
0.96
20-min
Mean
SD
22.9
3.18
23.0
3.34
0.92
25-min
Mean
SD
22.2
3.12
22.3
3.31
0.92
30-min (n=30)
Mean
SD
N=15
22.1
3.93
N=15
22.2
4.00
0.96
40-min (n=20)
Mean
SD
N=10
22.2
2.35
N=10
21.9
2.28
0.78
45-min (n=14)
Mean
SD
N=7
21.7
2.45
N=7
21.7
3.45
1.00
$ Not statistically significant
The distribution of cases and the mean values of AWP were observed to be generally not statistically significant 
between Group I and Group II at all the different time points.
Table 13: Distribution of cases by groups and attempt Proseal$
(n=20)
Attempt Gr. I Gr. II
No. % No. % p-value
1 Yes
2 No
18
2
90.0
10.0
18
2
90.0
10.0
1.00
$ Not statistically significant
Table 14: Distribution of cases by groups and attempt Ryle’s tube$
(n=20)
Attempt Gr. I Gr. II
No. % No. % p-value
1 Yes
2 No
18
2
90.0
10.0
18
2
90.0
10.0
1.00
$ Not statistically significant
Table 15: Distribution of cases by groups and GD score$
(n=20)
GD score Gr. I Gr. II
No. % No. % p-value
1 
2 
18
2
90.0
10.0
18
2
90.0
10.0
1.00
$ Not statistically significant
All of the above factors are equally distributed among the two groups in various categories and 
hence are not statistically significant.
DISCUSSION
The  proseal  LMA  designed  by  Dr.  Archie  Brain  is  based  on  the  LMA  and  was 
introduced in 2000.
The inventor’s aims of the modifications are (i) avoidance of gastric inflation during 
controlled ventilation. (ii) Less need for tight occlusion of the upper oesophageal sphincter 
(UES)  by  the  mask tip  in  the  event  of  regurgitation,  because  of  the  presence of  DT;  (iii) 
Opportunity  to  pass  an  orogastric  tube  (OGT)  (iv)  Channeling  of  regurgitated  stomach 
contents. Changes were also designed to improve airway seal. An important design function of 
the DT was to allow rapid diagnosis of mask misplacement.
When PLMA is correctly positioned, the airway orifice lies over the glottis and the DT 
tip lies  behind the cricoid cartilage at  the origin of  esophagus.  Airway and DT each form 
uninterrupted routes from these sites to outside of the mouth. This functional separation of the 
respiratory and gastrointestinal tracts is important in understanding potential advantages of the 
PLMA over the LMA and other supraglottic airway devices. In this regard one might consider 
the PLMA to act as an “artificial Larynx”,  rather than simply an airway tube.
Previous laryngeal mask studies indicate only minor haemodynamic responses to LMA 
insertion with a 0-20% increase in heart rate and mean arterial pressure 51. Brawn et al 52 stated 
that haemodynamic responses to PLMA insertion were similar to those of a LMA, in their 
randomized comparative trial of 280 patients anaesthetized  with a standard technique. Two 
randomized  studies  of  335  patients  with  varying  anaesthetic  techniques  reported 
haemodynamic variables change less than 10% in PLMA 53, 54.
In  this  study,  the  heart  rate,  systolic  blood pressure,  diastolic  blood pressure,  mean 
arterial  blood  pressure  were  monitored  before  induction,  1  min,5  min  after  insertion  / 
intubation, then 5 min after pneumoperitonium, and every 5min till end of surgery and 5 min 
after Extubation / Removal, and compared between Group I (ETT) and Group II (PLMA).
The distribution of cases by grade of HR, SBP, DBP and MAP, the mean values were 
observed to be statistically significant (P<0.05) between Group I (ETT) and Group II (PLMA) 
at every time points mentioned above.
The Group II PLMA is more haemodynamically stable than Group I ETT which was in 
concordance with the study done by EC-Ganzavria et al 6.
Regarding  ventilatory  parameters   the  SPO2,  ETCo2,  TV  &  RR,  Fio2,  and  Airway 
Pressure were monitored before induction, 1 min & 5min after intubation / Insertion, 5min after 
pneumoperitoneum then every 5 min till end of surgery, and compared between Group I (ETT) 
& Group II (PLMA).
The distribution of cases by grade of SPO2, ETCO2,  TV & RR, FIO2 ,  and Airway 
Pressure, the mean values were not statistically significant (P>0.05) between Group I (ETT) & 
Group II (PLMA) at every time point mentioned  above. This was in concordance with studies 
done by maltby et al 3,4 and piper SN et al 5.
The overall  proseal LMA insertion success reported in 33 studies,  and 2,581 PLMA 
Insertions ranged from 90-100% 2, 39, 9, 47, 13.
First  time  proseal  LMA insertion  success  reported  in  28  studies,  and  2,388  PLMA 
insertions ranges from 76% to 100% .37.3, 2, 39, 9,47,3.
In this study the PLMA was correctly placed in first attempt in 18 cases (90%). In 1st 
patient PLMA could not be placed correctly even after 3 attempts. And in the 2nd patient  the 
PLMA  was  inserted  in  the  second  attempts.  This  goes  with  accordance  with  the  above 
mentioned studies.   
Endotracheal intubation  was successful in first attempt in all 20 cases.
Regarding orogastric Tube (OGT) insertion, seventeen studies with 1,384 attempts via 
PLMA drain tube reported 95% first time OGT passage 2, 4 & 12, 55, 52, 3. 
Higher success rates for OGT passage (up to 100%) are reported when efforts are made 
to eliminate folding of mask tip 12, 14.
In this study OGT insertion was a success in first  attempt in 18 (90%) cases and in 
second attempt in 2 cases via PLMA drains tube.
OGT insertion after intubating with ETT, was successful in the first attempt in all cases 
(20).
Design and performance features of the PLMA are expected to reduce gastric distension, 
regurgitation and pulmonary aspiration compared to the LMA.
Miller et al 56 stated that PLMA provided better airway protection during regurgitation 
than LMA. Keller C. et al  57 concluded that a properly positioned PLMA isolates the airway 
from fluid within the hypopharynx.
In this study, the occurrence of regurgitation if any, was tested using litmus paper on the 
posterior surface of the PLMA, immediately after its removal. None of the patients showed any 
signs of regurgitation. 
In this study gastric distension score was not statistically significant between Group I 
(ETT) and Group II (PLMA). The highest gastric distension score -2 was seen in two patients 
in both groups.
SUMMARY
The  comparative  evaluation  of  the  proseal  LMA  with  tracheal  intubation  for 
laparoscopic surgeries showed no significant difference between the two groups based on the 
demographic variables. The PLMA group maintained  better haemodynamic stability than ETT 
group throughout the procedure.  The ventilatory parameters  (SPO2,  ETCo2,  TV&RR, FIO2, 
Airway Pressure) showed no significant difference between 2 groups. The first time insertion 
success rate was 90% in PLMA group & 100% in ETT group. The first time passage of an 
OGT was 90% in PLMA group & 100% in ETT Group. There was no significant difference 
between the two groups based on gastric distension score noted by surgeon.
CONCLUSION
0n comparing Proseal LMA and endotracheal tube for laparoscopic surgeries,  it  was 
found that the haemodynamics were more stable when Proseal LMA was used. Proseal LMA 
was as effective as endotracheal tube during positive pressure ventilation in preventing gastric 
distension and aspiration when correctly placed. So Proseal LMA is an effective alternative to 
endotracheal  tube  in  patients  where  the  haemodynamic  stability  is  much  desirable  during 
laparoscopic surgeries.
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COMPARISON OF LMA-PROSEAL AND ET FOR LAPRASCOPIC 
INTRAABDOMINAL SURGERY
NAME : AGE / SEX:
I.P.NO.: 
WEIGHT : HEIGHT: 
PHYSICAL STATUS:           ASA
MPC: ETT/LMA-PROSEAL:
VITAL SIGNS:      PRE OP:
PULSE: BP:
RESP RATE:
BLOOD INV:
CXR:
ECG:
PRE MEDICATION :
Inj. Glycopyrrolate 0.2mg I.V.
Inj. Midazolam 1mg I.V. just before procedure
Inj. Metaclopramide 10mg I.V.
Inj. Ranitidine 50mg I.V
INDUCTION
Inj. Propofol 2.5mg/kg I.V.
Inj. Fentanyl 2µg/kg I.V.
Inj. Vecuronium 0.1mg/kg I.V.
MAINTENANCE: N2O : O2 66.33% + Isoflurane
PARAMETERS: 
1. HEMODYNAMIC STABILITY : 
HR SOSTOLIC 
BP
DIASTOLIC 
BP
MAP
Before induction
One  minute  after  insertion  / 
intubation
5  minute  after  insertion  / 
intubation
5 minute after 
pneumoperitoneum
After estuation / removal 
2. ADEQUACY OF VENTILATION
SPO2 PET CO2 V RR Fio2 PAP
Before induction
One  minute  after  insertion  / 
intubation
5  minute  after  insertion  / 
intubation
5 minute after 
pneumoperitoneum
After estuation / removal
Oxygenation :- Optimal / suboptimal/failed
Ventilation: Optimal / suboptimal/failed
 INTRA ABDOMINAL PRESSURE ARE KEPT BETWEEN 12-14 mm Hg
 EASE OF PLACEMENT OF PROSEAL:   1 / 2 / 3 FAILED
 EASE OF PLACEMENT OF RYLE’S TUBE:  1 / 2 / 3  FAILED
 EPISODES OF GASTRIC DISTENSION :
   (Noted by surgeons)
INTRA OP PROBLEMS
 ASPIRATION – REGURGITATION 
 LITMUS PAPER TEST: POSITIVE / NEGATIVE
 HYPOXIA
 HYPERCARBIA
 BRONCHOSPASM
 TONGUE – LIP- DENTAL TRAUMA
POST-OP PROBLEMS
 COUGH
 SORE THROAT
 NAUSEA
 VOMITING
